16 Jul, 15:54 - Indian

Nifty 50 25212.05 (0.06)

Nifty Midcap 100 59620.65 (0.01)

Nifty Next 50 68870.55 (0.21)

Nifty IT 37660.75 (0.63)

Nifty Bank 57168.95 (0.28)

SENSEX 82634.48 (0.08)

Nifty Pharma 22593.9 (-0.32)

Nifty Smallcap 100 19140.05 (0.03)

16 Jul, 15:54 - Global

NIKKEI 225 39663.4 (-0.04)

HANG SENG 24517.77 (-0.29)

S&P 6290.75 (-0.08)


Corporate News

You are Here : Home > News > Corporate News >

(12 Mar 2025, 12:59)

Zydus Lifesciences receives USFDA approval for Methenamine Hippurate Tablets


Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) to manufacture Methenamine Hippurate Tablets USP, 1 gram (USRLD: Hiprex® Tablets, 1 gram).

Methenamine Hippurate tablets are indicated for prophylactic or suppressive treatment of frequently recurring urinary tract infections when long-term therapy is considered necessary.

Methenamine Hippurate tablets will be produced at Zydus Lifesciences (SEZ), Ahmedabad.

Methenamine Hippurate tablets had annual sales of USD 32.6 mn in the United States (IQVIA MAT January 2025).


More News
More Company News View Company Information

Capital Market Publishers India Pvt. Ltd

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071, India.

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

Copyright @ Capital Market Publishers India Pvt.Ltd

Designed, Developed and maintained by CMOTS Infotech (ISO 9001:2015 Certified)

Site best viewed in Internet Explorer Edge ,   Google Chrome 115.0.5790.111 + ,   Mozilla Firefox 115.0.3 + ,   Opera 30.0+, Safari 16.4.1 +